Page 7 of 11
Organic & Biomolecular Chemistry
Please do not adjust margins
Journal Name
ARTICLE
mmol) diastereomerically pure adduct 11a (308 mg, 0.83 mmol,
83% yield) was isolated as a white solid after chromatographic
purification (60:40 CH2Cl2/Hexanes). Mp: 130–131 °C. Rf = 0.3
(60:40 CH2Cl2/Hexanes). [α]D20 = +84.0 (c 1.0, CHCl3). IR (ATR): 2970,
187.0, 172.7, 83.1, 69.1 (×2), 66.1, 64.9, 59.7, 42.3, 4V0ie.1w,A3rt6ic.l0e O(×nl2in)e,
25.9, 25.7, 17.1, 14.6, 6.8, 4.3, 4.2, 1.4. HRDMOSI:(1E0S.1I)0:3m9//Cz8OcaBl0cd10.7f4oAr
C21H37N2O3S [M+H]+: 397.2519; found: 397.2524.
1
2926, 1717, 1178, 1357, 1138, 943, 800, 601 cm–1. H NMR (400
(S)-4-tert-Butyl-N-[(S)-2-(2,2,6,6-tetramethylpiperidin-1-yloxy)-5-
hexenoyl]-1,3-oxazolidine-2-thione (11f). Starting from (S) 4-tert-
butyl-N-(5-hexenoyl)-1,3-oxazolidine-2-thione (5f, 255 mg, 1.0
mmol) diastereomerically pure adduct 11f (368 mg, 0.90 mmol, 90%
MHz, CDCl3): δ 6.57 (q, J = 6.8 Hz, 1H), 4.66 (dd, J = 7.4, 1.4 Hz, 1H),
4.45 (dd, J = 9.5, 1.4 Hz, 1H), 4.28 (dd, J = 9.5, 7.4 Hz, 1H), 1.50–1.15
(m, 18H), 1.41 (d, J = 6.8 Hz, 3H), 0.98 (s, 9H). 13C NMR (100.6 MHz,
CDCl3): δ 186.9, 175.3, 79.4, 69.2, 66.0, 59.6, 40.2, 36.1, 34.0, 26.0,
20.2, 19.3, 17.1. HRMS (ESI): m/z calcd. for C19H35N2O3S [M+H]+:
371.2363; found: 371.2359.
yield) was isolated as
a
white solid after chromatographic
20
purification. Mp: 94–95 °C. Rf = 0.8 (CH2Cl2). [α]D = +96.9 (c 1.0,
CHCl3). IR (ATR): 2966, 2922, 2862, 1716, 1475, 1360, 1327, 1297,
1179, 1134 cm–1. 1H NMR (400 MHz, CDCl3): δ 6.66 (dd, J = 7.0, 3.2
Hz, 1H), 5.83–5.71 (m, 1H), 5.02–4.96 (m, 1H), 4.98–4.91 (m, 1H),
4.63 (dd, J = 7.3, 1.3 Hz, 1H), 4.45 (dd, J = 9.5, 1.3 Hz, 1H), 4.26 (dd, J
= 9.5, 7.3 Hz, 1H), 2.23–2.11 (m, 2H), 2.02–1.90 (m, 1H), 1.89–1.78
(m, 1H), 1.47 (br s, 6H), 1.18 (s, 6H), 1.16 (s, 6H), 0.99 (s, 9H). 13C
NMR (100.6 MHz, CDCl3): δ 186.9, 173.7, 137.9, 114.7, 81.2, 69.2,
66.5, 40.3, 36.2, 31.1, 27.4, 26.1, 17.1. HRMS (ESI): m/z calcd. for
C22H39N2O3S [M+H]+: 411.2676; found: 411.2680.
(S)-4-tert-Butyl-N-[(S)-3-phenyl-2-(2,2,6,6-tetramethylpiperidin-1-
yloxy)propanoyl]-1,3-oxazolidine-2-thione (11b). Starting from (S)
4-tert-butyl-N-(3-phenylpropanoyl)-1,3-oxazolidine-2-thione
(5b,
291 mg, 1.0 mmol) diastereomerically pure adduct 11b (361 mg,
0.81 mmol, 81% yield) was isolated as a white solid after
chromatographic purification (CH2Cl2). Mp: 138–139 °C. Rf = 0.8
20
(CH2Cl2). [α]D = +87.0 (c 1.0, CHCl3). IR (ATR): 2962, 2922, 2862,
1713, 1479, 1368, 1349, 1308, 1182, 1149 cm–1. 1H NMR (400 MHz,
CDCl3): δ 7.29–7.15 (m, 5H), 7.00 (dd, J = 10.7, 6.0 Hz, 1H), 3.97–
3.91 (m, 2H), 3.47 (dd, J = 12.6, 6.0 Hz, 1H), 2.92–2.85 (m, 2H),
1.57–1.13 (m, 18H), 0.85 (s, 9H). 13C NMR (100.6 MHz, CDCl3): δ
187.3, 175.1, 135.3, 129.6, 128.4, 126.9, 80.8, 68.7, 66.7, 59.9, 40.4,
40.2, 35.9, 34.1, 33.5, 26.1, 20.2, 20.1, 17.2. HRMS (ESI): m/z calcd.
for C24H39N2O3S [M+H]+: 447.2676; found: 447.2682.
(S)-4-tert-Butyl-N-[(S)-5-methoxy-2-(2,2,6,6-tetramethylpiperidin-
1-yloxy)-5-oxopentanoyl]-1,3-oxazolidine-2-thione (11g). Starting
from
(S)
4-tert-butyl-N-(5-methoxy-5-oxopentanoyl)-1,3-
oxazolidine-2-thione (5g, 287 mg, 1.0 mmol) diastereomerically
pure adduct 11g (413 mg, 0.93 mmol, 93% yield) was isolated as a
white solid after chromatographic purification (95:5 CH2Cl2/EtOAc).
20
Mp: 104–105 °C. Rf = 0.4 (CH2Cl2). [α]D = +102.5 (c 1.0, CHCl3). IR
(ATR): 2929, 1731, 1713, 1360, 1320, 1297, 1167, 1142, 934 cm–1.
1H NMR (400 MHz, CDCl3): δ 6.71 (dd, J = 6.1, 2.3 Hz, 1H), 4.54–4.48
(m, 1H), 4.50–4.45 (m, 1H), 4.45–4.40 (m, 1H), 3.61 (s, 3H), 2.61–
2.51 (m, 1H), 2.41–2.30 (m, 2H), 2.20–2.10 (m, 1H), 1.47 (s, 6H),
1.17 (s, 6H), 1.15 (s, 6H), 0.96 (s, 9H). 13C NMR (100.6 MHz, CDCl3): δ
187.3, 173.9, 173.1, 80.1, 69.3, 66.4, 51.4, 40.0, 35.8, 26.4, 25.9,
25.6, 16.9. HRMS (ESI): m/z calcd. for C22H39N2O5S [M+H]+:
443.2574; found: 443.2576.
(S)-4-tert-Butyl-N-[(S)-3-methyl-2-(2,2,6,6-tetramethylpiperidin-1-
yloxy)butanoyl]-1,3-oxazolidine-2-thione (11c). Starting from (S) 4-
tert-butyl-N-(3-methylbutanoyl)-1,3-oxazolidine-2-thione (5c, 243
mg, 1.0 mmol) diastereomerically pure adduct 11c (320 mg, 0.80
mmol, 80% yield) was isolated as
a
white solid after
chromatographic purification (CH2Cl2). Mp: 111–112 °C. Rf = 0.7
20
(CH2Cl2). [α]D = +97.0 (c 1.0, CHCl3). IR (ATR): 2962, 2929, 1698,
1
1468, 1349, 1301, 1171, 1145 cm–1. H NMR (400 MHz, CDCl3): δ
6.75 (d, J = 5.4 Hz, 1H), 4.62 (dd, J = 7.3, 1.3 Hz, 1H), 4.44 (dd, J =
9.5, 1.3 Hz, 1H), 4.21 (dd, J = 9.5, 7.3 Hz, 1H), 2.49–2.36 (m, 1H),
1.63–1.09 (m, 18H), 1.02 (d, J = 6.7 Hz, 3H), 0.99 (s, 9H), 0.90 (d, J =
7.1 Hz, 3H). 13C NMR (100.6 MHz, CDCl3): δ 187.6, 173.0, 82.3, 69.2,
66.7, 59.8, 40.4, 36.2, 34.2, 31.7, 26.2, 25.8, 22.4, 22.3, 20.3, 17.9,
17.1, 16.8. HRMS (ESI): m/z calcd. for C21H39N2O3S [M+H]+:
399.2676; found: 399.2679.
Removal of the chiral auxiliary
(S)-2-(2,2,6,6-Tetramethylpiperidin-1-yloxy)-1-propanol (21a).
A
solution of 11a (74 mg, 0.20 mmol) in THF (1.5 mL) was added to a
solution of NaBH4 (31 mg, 0.8 mmol, 4 equiv) in 40:1 THF/H2O (1.4
mL) at 0 °C under N2 and the resultant mixture was stirred at room
temperature for 2 h. The mixture was then diluted with Et2O (20
mL), washed with 1 M NaOH (3 × 20 mL), water (20 mL), and brine
(20 mL). The organic layer was dried (MgSO4), and concentrated.
The crude was purified by column chromatography (90:10
Hexanes/EtOAc) to give 36 mg (0.17 mmol, 84% yield) of pure
alcohol 21a as a colourless oil. The aqueous phase was acidified and
extracted with CH2Cl2 (3 × 20 mL) to recover 34 mg (90%) of pure
(S)-4-tert-Butyl-N-[(S)-2-cyclopropyl-2-(2,2,6,6-
tetramethylpiperidin-1-yloxy)acetyl]-1,3-oxazolidine-2-thione
(11d). Starting from (S) 4-tert-butyl-N-(2-cyclopropylacetyl)-1,3-
oxazolidine-2-thione (5d, 241 mg, 1.0 mmol) diastereomerically
pure adduct 11d (308 mg, 0.78 mmol, 78% yield) was isolated as a
white solid after chromatographic purification (95:5 CH2Cl2/EtOAc).
20
auxiliary 5. Rf = 0.2 (90:10 Hexanes/EtOAc). [α]D = –35.6 (c 1.0,
20
Mp: 107–108 °C. Rf = 0.4 (CH2Cl2). [α]D = +112.1 (c 1.0, CHCl3). IR
CHCl3). IR (ATR): 3376 (br), 2972, 2928, 1453, 1375, 1162, 1131,
1043 cm–1. 1H NMR (400 MHz, CDCl3): δ 5.53 (s br, 1H), 4.38 (dqd, J
= 9.3, 6.3, 2.2 Hz, 1H), 3.90 (dd, J = 11.9, 9.3 Hz, 1H), 3.57 (dd, J =
11.9, 2.2 Hz, 1H), 1.60–1.25 (m, 6H), 1.32 (s, 3H), 1.30 (s, 3H), 1.15
(s, 3H), 1.11 (s, 3H), 1.01 (d, J = 6.3 Hz, 3H). 13C NMR (100.6 MHz,
(ATR): 2958, 2925, 1716, 1483, 1353, 1316, 1182, 1138, 949 cm–1.
1H NMR (400 MHz, CDCl3): δ 6.64 (d, J = 8.4 Hz, 1H), 4.64 (dd, J =
7.4, 1.4 Hz, 1H), 4.46 (dd, J = 9.5, 1.4 Hz, 1H), 4.26 (dd, J = 9.5, 7.4
Hz, 1H), 1.47–1.15 (m, 19H), 0.97 (s, 9H), 0.71–0.56 (m, 2H), 0.54–
0.45 (m, 1H), 0.29–0.21 (m, 1H). 13C NMR (100.6 MHz, CDCl3): δ
This journal is © The Royal Society of Chemistry 20xx
J. Name., 2013, 00, 1-3 | 7
Please do not adjust margins